Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy

Scand J Rheumatol. 2022 Mar;51(2):164-165. doi: 10.1080/03009742.2021.1972518. Epub 2021 Oct 13.

Authors

A Biglia¹, E Bozzalla Cassione¹, G Zanframundo¹, L Cavagna¹, V Morandi¹, F Bobbio Pallavicini¹, A Valentini², G Cavenaghi³, C Montecucco¹

Affiliations

¹ Rheumatology Department, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy.
² Radiology Department, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy.
³ Nuclear Medicine Department, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy.

PMID: 34643167
DOI: 10.1080/03009742.2021.1972518

No abstract available

Publication types

Letter

MeSH terms

Autoantibodies
Dermatomyositis* / complications
Dermatomyositis* / drug therapy
Humans
Immunosuppression Therapy
Interferon-Induced Helicase, IFIH1
Nocardia Infections* / complications
Nocardia Infections* / diagnosis
Nocardia Infections* / drug therapy

Substances

Autoantibodies
Interferon-Induced Helicase, IFIH1

Supplementary concepts

Amyopathic dermatomyositis